Blaszyk Michael D's Form 4 filing
ImmunityBio, Inc. (IBRX) · filed Jun 5, 2023
- Accession no.
- 0001326110-23-000072
- Filed
- Jun 5, 2023
- Trade date
- Jun 5, 2023
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market purchases total $198.0K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Blaszyk Michael DCIK 0001371407 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 5, 2023 | Common Stock | PPurchaseAcquired | +23,430 | $2.72 | +$63,729.6 | 23,430 | Indirect | |
| Jun 5, 2023 | Common Stock | PPurchaseAcquired | +48,000 | $2.77 | +$132,960 | 71,430 | Indirect | |
| Jun 5, 2023 | Common Stock | PPurchaseAcquired | +485 | $2.75 | +$1,333.75 | 71,915 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.